Business Context and Reporting Period
Molina Healthcare, Inc. (MOH) filed a Form 8-K on November 18, 2024, reporting the completion of a private offering of senior notes. The company is a Delaware corporation headquartered in Long Beach, California.
Key Financial Metrics and Transaction Details
The filing details a debt financing transaction rather than operational financial results. Key metrics include:
- Principal Amount: $750.0 million aggregate principal amount.
- Instrument: 6.250% Senior Notes due 2033.
- Interest Rate: 6.250% per year, payable semi-annually in arrears starting July 15, 2025.
- Maturity Date: January 15, 2033.
- Settlement Date: November 18, 2024.
The filing text does not provide current revenue, profit, cash flow, or existing debt levels.
Material Changes and Debt Structure
The primary material change is the addition of $750.0 million in new senior unsecured debt. The Notes rank pari passu with all existing and future senior debt and are senior to subordinated debt. They are effectively subordinated to secured debt and structurally subordinated to subsidiary liabilities. The Notes are not initially guaranteed by subsidiaries, though future domestic unregulated subsidiaries guaranteeing other indebtedness will be required to guarantee these Notes.
Terms, Covenants, and Risks
Redemption and Repurchase:
- Optional Redemption: Redeemable on or after January 15, 2028. Up to 40% may be redeemed prior to this date using proceeds from equity offerings. Early redemption prior to 2028 is possible with a "make-whole premium."
- Change of Control: Holders have the right to require repurchase upon a Change of Control if the Company does not exercise its redemption right.
Covenants: The Indenture restricts the Company's ability to create certain liens, enter into sale and leaseback transactions, issue secured indebtedness without securing the Notes pari passu, and consolidate or merge without specific provisions.
Risks: The filing notes customary events of default, including cross acceleration to certain other indebtedness. The Notes are not registered for resale under the Securities Act of 1933.
Investor Verification Checklist
- Verify the use of proceeds from the $750.0 million offering (not explicitly stated in this filing).
- Review the full Indenture (Exhibit 4.1) for detailed covenant restrictions and definitions of "Change of Control."
- Confirm the impact of this new debt on the company's leverage ratios and interest coverage.
- Monitor the press release (Exhibit 99.1) for management commentary on the strategic rationale for the offering.